Commentary: COVID-19 in patients with diabetes

Affiliations

¹ Dalton Cardiovascular Research Center, Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO, USA. Electronic address: hillmi@missouri.edu.
² Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Section of Endocrinology, Boston VA Healthcare System, Harvard Medical School, Boston, MA, USA.
³ Dalton Cardiovascular Research Center, Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO, USA; Diabetes and Cardiovascular Center, University of Missouri-Columbia School of Medicine, Columbia, MO, USA. Electronic address: sowersj@health.missouri.edu.

Michael A Hill et al. Metabolism. 2020 Jun.

. 2020 Jun:107:154217.

doi: 10.1016/j.metabol.2020.154217. Epub 2020 Mar 24.

¹ Dalton Cardiovascular Research Center, Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO, USA. Electronic address: hillmi@missouri.edu.
² Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Section of Endocrinology, Boston VA Healthcare System, Harvard Medical School, Boston, MA, USA.
³ Dalton Cardiovascular Research Center, Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO, USA; Diabetes and Cardiovascular Center, University of Missouri-Columbia School of Medicine, Columbia, MO, USA. Electronic address: sowersj@health.missouri.edu.

No abstract available

Conflict of interest statement

Declaration of competing interest The authors declare no conflict of interest.

Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity.
Klonoff DC, Umpierrez GE. Klonoff DC, et al. Metabolism. 2020 Jul;108:154224. doi: 10.1016/j.metabol.2020.154224. Epub 2020 Apr 7. Metabolism. 2020. PMID: 32275971 Free PMC article. No abstract available.

1. Yang X., Yu Y., Xu J. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 doi: 10.1016/S2213-2600(20)30079-5. Feb 24. pii: S2213-2600(20)30079-5. - DOI - PMC - PubMed
1. Guan W., Ni Z., Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 doi: 10.1056/NEJMoa2002032. Feb 28. - DOI - PMC - PubMed
1. Zhang J.J., Dong X., Cao Y.Y. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy. 2020 doi: 10.1111/all.14238. - DOI - PubMed
1. Li B. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020 doi: 10.1007/s00392-020-01626-9. Mar 11. - DOI - PMC - PubMed
1. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020 doi: 10.1001/jama.2020.2648. February 24. - DOI - PubMed